JP2024511945A - 淋菌感染症の治療のための方法および材料 - Google Patents
淋菌感染症の治療のための方法および材料 Download PDFInfo
- Publication number
- JP2024511945A JP2024511945A JP2023555485A JP2023555485A JP2024511945A JP 2024511945 A JP2024511945 A JP 2024511945A JP 2023555485 A JP2023555485 A JP 2023555485A JP 2023555485 A JP2023555485 A JP 2023555485A JP 2024511945 A JP2024511945 A JP 2024511945A
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- aryl
- group
- formula
- heterocyclyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163166309P | 2021-03-26 | 2021-03-26 | |
| US63/166,309 | 2021-03-26 | ||
| PCT/US2022/021467 WO2022204231A2 (en) | 2021-03-26 | 2022-03-23 | Methods and materials for treatment of neisseria gonorrhoeae infection |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024511945A true JP2024511945A (ja) | 2024-03-18 |
| JP2024511945A5 JP2024511945A5 (cg-RX-API-DMAC7.html) | 2025-03-31 |
Family
ID=83398108
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023555485A Pending JP2024511945A (ja) | 2021-03-26 | 2022-03-23 | 淋菌感染症の治療のための方法および材料 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20250339401A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4313040A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2024511945A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20230161962A (cg-RX-API-DMAC7.html) |
| CN (1) | CN117396201A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2022244356A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3211535A1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2022204231A2 (cg-RX-API-DMAC7.html) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2023150719A1 (en) * | 2022-02-03 | 2023-08-10 | Purdue Research Foundation | Alpha-methylene and aminomethyl lactones and lactams for treatment of clostridioides difficile infection (cdi) |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2005500289A (ja) * | 2001-06-13 | 2005-01-06 | マグナケム インターナショナル ラボラトリーズ, インコーポレイテッド | ラクトン処方物および使用方法 |
| BRPI0620157A2 (pt) * | 2005-12-15 | 2011-12-20 | Activbiotics Pharma Llc | usos de rifamicinas |
| US20210317099A1 (en) * | 2020-04-09 | 2021-10-14 | Purdue Research Foundation | Safer, potent, and fast acting antimicrobial agents |
-
2022
- 2022-03-23 CA CA3211535A patent/CA3211535A1/en active Pending
- 2022-03-23 KR KR1020237031684A patent/KR20230161962A/ko active Pending
- 2022-03-23 CN CN202280024693.0A patent/CN117396201A/zh active Pending
- 2022-03-23 JP JP2023555485A patent/JP2024511945A/ja active Pending
- 2022-03-23 US US18/550,288 patent/US20250339401A1/en active Pending
- 2022-03-23 AU AU2022244356A patent/AU2022244356A1/en active Pending
- 2022-03-23 EP EP22776535.1A patent/EP4313040A4/en active Pending
- 2022-03-23 WO PCT/US2022/021467 patent/WO2022204231A2/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| WO2022204231A3 (en) | 2022-12-29 |
| KR20230161962A (ko) | 2023-11-28 |
| CA3211535A1 (en) | 2022-09-29 |
| CN117396201A (zh) | 2024-01-12 |
| WO2022204231A2 (en) | 2022-09-29 |
| US20250339401A1 (en) | 2025-11-06 |
| EP4313040A2 (en) | 2024-02-07 |
| AU2022244356A1 (en) | 2023-09-28 |
| EP4313040A4 (en) | 2025-02-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7099824B2 (ja) | 抗菌化合物 | |
| CN104470921B (zh) | 吡啶并嘧啶类衍生物、其制备方法及其在医药上的应用 | |
| AU2020409843B2 (en) | Novel compounds and their use | |
| EP3057422B1 (en) | Quinolinyl modulators of ror(gamma)t | |
| WO2008081914A1 (ja) | Plk1阻害剤としての新規アミノピリミジン誘導体 | |
| US20200165239A1 (en) | Protein kinase inhibitors, preparation method and medical use thereof | |
| US20240132515A1 (en) | Toxin molecule suitable for antibody-drug conjugate | |
| KR20240056750A (ko) | Ahr 효능제 | |
| CN104211708B (zh) | 苯并噁嗪酮衍生物及其作为抗菌剂的应用 | |
| RU2548031C2 (ru) | Способ получения (+)-1,4-дигидро-7-[(3s,4s)-3-метокси-4-(метиламино)-1-пирролидинил]-4-оксо-1-(2-тиазолил)-1,8-нафтиридин-3-карбоновой кислоты | |
| CN107459476B (zh) | 反吲哚啉环丙胺类化合物及其制备方法、药物组合物和用途 | |
| US20210317099A1 (en) | Safer, potent, and fast acting antimicrobial agents | |
| BRPI0911991B1 (pt) | Derivados de 5-hidroximetil-oxazolidin-2-ona para o tratamento de doenças intestinais bacterianas | |
| EA011359B1 (ru) | Замещенные хинолины и их применение в качестве микобактериальных ингибиторов | |
| CN114957296B (zh) | 一类新型阿尔茨海默病检测探针及其生物应用 | |
| JPH0363274A (ja) | 6,11―ジヒドロ―5H―ピリド[2,3―b][1,5]ベンゾジアゼピン―5―オン及び―チオン並びに該化合物のAIDSの予防又は治療における使用法 | |
| AU2022244356A1 (en) | Methods and materials for treatment of neisseria gonorrhoeae infection | |
| KR102650441B1 (ko) | 내부 사이클릭 설피아미딘 아미드-아릴 아미드 화합물 및 이의 b형 간염 치료를 위한 용도 | |
| US12378211B2 (en) | Carbonic anhydrase inhibitors and antibiotics against multidrug resistant bacteria | |
| CA3161108C (en) | Pyrido-azepine compounds and their uses as antibiotics | |
| US20250195490A1 (en) | Alpha-methylene and aminomethyl lactones and lactams for treatment of clostridioides difficile infection (cdi) | |
| CN117700351B (zh) | 邻苯二甲酰亚胺类衍生物、包含其的药物组合物及其医药用途 | |
| CN109251158A (zh) | 硫脒酰胺类化合物及其用于乙型肝炎治疗的用途 | |
| US20190256452A1 (en) | Polyamine compounds targeting the efflux pumps of multi-drug resistant bacterial pathogens and methods of using the same | |
| WO2020115547A2 (en) | Pyrrolo[2,3-d]pyrimidin-2-one antimicrobial compounds |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20250321 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20250321 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20260407 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20260703 |
|
| A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20260707 |